Clincosm LogoSign in Get a demo

dermatitis, atopic

Showing 1 - 25 of 162
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatitis, Atopic Trial (Monoclonal antibody BAT6026, sodium chloride injection)

Not yet recruiting
  • Dermatitis, Atopic
  • Monoclonal antibody BAT6026
  • sodium chloride injection
  • (no location specified)
Oct 19, 2023

Dermatitis, Atopic Trial (GSK1070806, Placebo)

Not yet recruiting
  • Dermatitis, Atopic
  • (no location specified)
Aug 22, 2023

Dermatitis, Atopic, Pruritus Trial in United States (ASN008, ASN008 Matching Vehicle)

Recruiting
  • Dermatitis, Atopic
  • Pruritus
  • Scottsdale, Arizona
  • +17 more
May 24, 2023

Medicine, Abrocitinib in People With Atopic Dermatitis

Recruiting
  • Dermatitis, Atopic
  • Seoul, Korea, Republic of
    Pfizer Tower
Jan 25, 2023

Dermatitis, Atopic Trial in United States (LY3471851, Placebo)

Completed
  • Dermatitis, Atopic
  • North Little Rock, Arkansas
  • +19 more
Jan 24, 2023

Dermatitis, Atopic Trial in Cypress, Las Vegas (GSK1070806, Placebo)

Recruiting
  • Dermatitis, Atopic
  • Cypress, California
  • +1 more
Jan 20, 2023

Dermatitis, Atopic Trial in Alken (MK-6194, Placebo)

Recruiting
  • Dermatitis, Atopic
  • MK-6194
  • Placebo
  • North Little Rock, Arkansas
  • +9 more
Jan 18, 2023

Dermatitis, Atopic Trial in Spain (Ciclosporin)

Recruiting
  • Dermatitis, Atopic
  • Badalona, Barcelona, Spain
  • +8 more
Jan 5, 2023

Dermatitis, Atopic, Eczema Trial in Worldwide (CC-93538, Placebo)

Completed
  • Dermatitis, Atopic
  • Eczema
  • Birmingham, Alabama
  • +156 more
Dec 12, 2022

Dermatitis, Atopic Trial in China (611 150mg, 611 300mg, 611 600mg)

Completed
  • Dermatitis, Atopic
  • 611 150mg
  • +3 more
  • Wuhu, Anhui, China
  • +4 more
Nov 30, 2022

Dermatitis, Atopic Trial in Toulouse (Clinical and instrumental measurements)

Terminated
  • Dermatitis, Atopic
  • Clinical and instrumental measurements
  • Toulouse, France
    Centre de Recherche sur la Peau
Nov 28, 2022

Dermatitis, Atopic Trial in Canada, Japan, United States (BI 655130, Placebo)

Completed
Has Results
  • Dermatitis, Atopic
  • BI 655130
  • Placebo
  • Scottsdale, Arizona
  • +22 more
Nov 15, 2022

Dermatitis, Atopic Trial in High Point (Gel Cream)

Completed
  • Dermatitis, Atopic
  • Gel Cream
  • High Point, North Carolina
    Dermatology Consulting Services, PLLC
Nov 4, 2022

Dermatitis, Atopic, Dermatitis, Eczema Trial in Japan (Lebrikizumab, Placebo, Topical Corticosteroid)

Active, not recruiting
  • Dermatitis, Atopic
  • +4 more
  • Ainokawa, Ichikawa-shi, Chiba, Japan
  • +36 more
Sep 19, 2022

Dermatitis, Atopic Trial in China (611 Q2W, 611 Q4W, Matching )

Not yet recruiting
  • Dermatitis, Atopic
  • 611 Q2W
  • +2 more
  • Beijing, Beijing, China
  • +4 more
Sep 15, 2022

Healthy, Dermatitis, Atopic Trial in Glendale (LY3844583, Placebo)

Recruiting
  • Healthy
  • Dermatitis, Atopic
  • Glendale, California
    Parexel Early Phase Unit at Glendale
Aug 17, 2022

Dermatitis, Atopic Trial in High Point (Wash IP, Cream IP)

Not yet recruiting
  • Dermatitis, Atopic
  • Wash IP
  • Cream IP
  • High Point, North Carolina
    Dermatology Consulting Services, PLLC
Aug 9, 2022

Food Hypersensitivity, Asthma in Children, Rhinitis, Allergic Trial

Not yet recruiting
  • Food Hypersensitivity
  • +3 more
    • (no location specified)
    Jul 20, 2022

    Dermatitis, Atopic Trial in Canada, Japan, United States (Spesolimab)

    Terminated
    Has Results
    • Dermatitis, Atopic
    • Scottsdale, Arizona
    • +9 more
    Jun 28, 2022

    Dermatitis, Atopic Trial in Canada, United States (Dupilumab)

    Active, not recruiting
    • Dermatitis, Atopic
    • Birmingham, Alabama
    • +77 more
    Jun 10, 2022

    Dermatitis, Atopic, Eczema Trial in Worldwide (Lebrikizumab, Lebrikizumab-matching Placebo)

    Recruiting
    • Dermatitis, Atopic
    • Eczema
    • Lebrikizumab
    • Lebrikizumab-matching Placebo
    • Nantes, Loira Atlantico, France
    • +1 more
    Jun 8, 2022

    Dermatitis, Atopic Trial in Germany

    Recruiting
    • Dermatitis, Atopic
      • Bramsche, Germany
      • +7 more
      May 23, 2022

      Dermatitis, Atopic Trial in Worldwide (Placebo, Bermekimab, Dupilumab)

      Terminated
      • Dermatitis, Atopic
      • Placebo
      • +2 more
      • Los Angeles, California
      • +41 more
      Apr 7, 2022

      Dermatitis, Atopic Trial in Argentina, United States (Bermekimab, Placebo)

      Terminated
      • Dermatitis, Atopic
      • Indianapolis, Indiana
      • +10 more
      Apr 7, 2022

      Dermatitis, Atopic Trial in France (Individual session therapeutic education, Phone Call)

      Terminated
      • Dermatitis, Atopic
      • Individual session therapeutic education
      • Phone Call
      • Bordeaux, France
      • +10 more
      Mar 24, 2022